Nirman Agri Genetics (NSE:NIRMAN) EBITDA: ₹300 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NIRMAN Nirman Agri Genetics Ltd NSE:NIRMAN
85 GF Score
Price ₹40.45
GF Value ₹857.60
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nirman Agri Genetics EBITDA?

Nirman Agri Genetics NSE:NIRMAN -1.46% 85 EBITDA is ₹300 Mil as of Sep. 2025. GuruFocus rates NSE:NIRMAN with a GF Score™ of 85/100 and a GF Value™ of ₹857.60 (Possible Value Trap). The stock has 4 warning signs investors should review.

Nirman Agri Genetics's EBITDA for the six months ended in Sep. 2025 was ₹153 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was ₹300 Mil.

During the past 12 months, the average EBITDA Growth Rate of Nirman Agri Genetics was 57.20% per year. During the past 3 years, the average EBITDA Growth Rate was 97.90% per year. During the past 5 years, the average EBITDA Growth Rate was 192.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 6 years, the highest 3-Year average EBITDA Growth Rate of Nirman Agri Genetics was 264.80% per year. The lowest was 97.90% per year. And the median was 202.50% per year.

Nirman Agri Genetics's EBITDA per Share for the six months ended in Sep. 2025 was ₹19.05. Its EBITDA per share for the trailing twelve months (TTM) ended in Sep. 2025 was ₹37.41.

During the past 12 months, the average EBITDA per Share Growth Rate of Nirman Agri Genetics was 45.80% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 85.60% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 184.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 6 years, the highest 3-Year average EBITDA per Share Growth Rate of Nirman Agri Genetics was 264.70% per year. The lowest was 85.60% per year. And the median was 202.60% per year.

Nirman Agri Genetics  (NSE:NIRMAN) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Nirman Agri Genetics EBITDA Related Terms


Nirman Agri Genetics EBITDA Historical Data

* Premium members only.

The historical data trend for Nirman Agri Genetics's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirman Agri Genetics EBITDA Chart

Nirman Agri Genetics Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EBITDA
Get a 7-Day Free Trial 2.36 34.49 43.62 114.78 267.29

Nirman Agri Genetics Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.42 70.37 120.23 147.06 152.60

NSE:NIRMAN vs CTVA, CF, MOS: EBITDA Comparison

For the Agricultural Inputs subindustry, Nirman Agri Genetics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nirman Agri Genetics EV-to-EBITDA vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Nirman Agri Genetics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nirman Agri Genetics's EV-to-EBITDA falls into.


NSE:NIRMAN
85GF Score
Nirman Agri Genetics Ltd NSE:NIRMAN
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Nirman Agri Genetics's EBITDA for the fiscal year that ended in Mar. 2025 is calculated as

Nirman Agri Genetics's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Mar. 2025, Nirman Agri Genetics's EBITDA was ₹267 Mil.

Nirman Agri Genetics's EBITDA for the quarter that ended in Sep. 2025 is calculated as

Nirman Agri Genetics's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Sep. 2025, Nirman Agri Genetics's EBITDA was ₹153 Mil.

EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹300 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of ₹300 Mil mean?
Nirman Agri Genetics (NSE:NIRMAN) has a EBITDA of ₹300 Mil as of Sep. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Nirman Agri Genetics.
Is Nirman Agri Genetics' EBITDA too high?
Nirman Agri Genetics' current EBITDA is ₹300 Mil. Overall, Nirman Agri Genetics has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nirman Agri Genetics' EBITDA compare to CTVA and CF?
Nirman Agri Genetics' EBITDA of ₹300 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for an Agriculture company?
A good EBITDA depends on the Agriculture industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Nirman Agri Genetics. Nirman Agri Genetics's current EBITDA is ₹300 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirman Agri Genetics stock overvalued right now?
Based on GuruFocus' analysis, Nirman Agri Genetics (NSE:NIRMAN) is currently considered Possible Value Trap. The stock's GF Value™ is ₹857.60, compared to a current price of ₹40.45 — trading 95.3% below its estimated fair value. The current EBITDA is ₹300 Mil. Nirman Agri Genetics' overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Nirman Agri Genetics (NSE:NIRMAN), the current EBITDA is ₹300 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nirman Agri Genetics (NSE:NIRMAN) Overvalued in 2026?

Based on GuruFocus' analysis, Nirman Agri Genetics stock appears to be undervalued. The current stock price of ₹40.45 is trading 95.3% below its estimated GF Value™ of ₹857.60. GuruFocus considers Nirman Agri Genetics to be Possible Value Trap.

Key valuation signals for NSE:NIRMAN:

  • EBITDA: ₹300 Mil
  • GF Value™: ₹857.60 vs. price of ₹40.45 (95.3% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the NSE:NIRMAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nirman Agri Genetics Business Description

Address 3rd floor, Samarth House, Opposite Titan World, Mahatma Nagar, Nashik, MH, IND, 422005
Nirman Agri Genetics Ltd is an organized Agri-Input company in India. It is in the business of production, processing, and marketing of high-quality hybrid seeds, pesticides, and bio-organic. These processes are used for different crops like corn, sunflower, cotton, paddy, grain sorghum, and others. It is engaged in the business of Agriculture Industry, Manufacturing & Processing of seeds. Its geographical segments include Revenue within India includes sales to customers located within India and Revenue outside India includes sales to customers located outside India including Export Benefits or Incentives.
85GF Score

Get the complete analysis for NSE:NIRMAN

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.45
Price
₹857.60
GF Value